Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The weight loss drug market could be worth $100 billion in the next few years. Naturally, other companies want in.
The EU’s antitrust investigation claims that China is artificially flooding the market with cheap EVs via enormous state subsidies.
Ethanol has been good to corn farmers. But when everybody starts switching to electric vehicles, where’s all that maize going to go?
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
McDonald’s has had a tenuous relationship with its franchise operators as of late. A new round of royalty fee hikes isn’t likely to help.
If Hollywood studios want to settle the current dual strike, they may have to get much more open about just how popular their shows are.
Unfortunately for the Lachlan Murdoch there is not much by way of peace in the kingdom, and indications are this may be a short reigns.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Federal Reserve chair Jerome Powell has met his match in the ongoing fight against inflation: skyrocketing oil costs.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.